Bijoy Hans Limited (BIJHANS) — BSE Stock Analysis

Sector: Healthcare. Industry: Medical Distribution.

Company Overview

Bijoy Hans Limited is a pharmaceutical and healthcare distributor headquartered in Guwahati, India. Established in 1985, the company specializes in the wholesale distribution and trading of pharmaceutical, medical, and cosmetic products, serving a range of clients across the health sector. Its portfolio includes bulk drugs and a variety of pharmaceutical formulations, such as tablets, capsules, syrups, suspensions, and powders. Bijoy Hans Limited focuses on key therapeutic segments, including antibiotics, cough/cold/allergy medications, H-1 receptor antagonists (used as anti-ulcerants), nutraceuticals, and NSAIDs. The company operates with a small-cap profile and has demonstrated both profitability and efficiency in recent periods, yet has seen lagging sales growth and returns on equity over the past few years. Bijoy Hans has maintained a low debt level and stable promoter holding, indicating a conservative approach to financial management. Situated in the broader healthcare and pharmaceutical industry, it plays a vital role in supplying essential medical goods and supporting healthcare infrastructure, particularly in its regional market.

Valuation Snapshot

• Market cap: —
• P/E: —
• P/B: —
• ROE: —

Blanket Finance is not a SEBI-registered investment adviser or research analyst. This content is for educational and informational purposes only.